Cargando…
Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients
To determine whether fluoroquinolone exposure is a risk factor for the isolation of Staphylococcus aureus and whether the effect is different for methicillin-resistant S. aureus (MRSA) versus methicillin-susceptible S. aureus (MSSA), we studied two case groups. The first case group included 222 pati...
Autores principales: | Weber, Stephen G., Gold, Howard S., Hooper, David C., Karchmer, A.W., Carmeli, Yehuda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035560/ https://www.ncbi.nlm.nih.gov/pubmed/14718085 http://dx.doi.org/10.3201/eid0911.030284 |
Ejemplares similares
-
Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada
por: LeBlanc, Louiselle, et al.
Publicado: (2006) -
Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003) -
Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission
por: Chowers, Michal, et al.
Publicado: (2015) -
Fluoroquinolone Metalloantibiotics: A Promising Approach against Methicillin-Resistant Staphylococcus aureus
por: Ferreira, Mariana, et al.
Publicado: (2020) -
Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit
por: Regev-Yochay, Gili, et al.
Publicado: (2005)